Journal of Medical Virology

Papers
(The H4-Index of Journal of Medical Virology is 79. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)
ArticleCitations
The cytokine storm and COVID‐19986
Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluation934
Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines596
Predictors of mortality in hospitalized COVID‐19 patients: A systematic review and meta‐analysis441
Epidemiology of COVID‐19: A systematic review and meta‐analysis of clinical characteristics, risk factors, and outcomes421
Omicron and Delta variant of SARS‐CoV‐2: A comparative computational study of spike protein404
False negative of RT‐PCR and prolonged nucleic acid conversion in COVID‐19: Rather than recurrence379
Post‐acute COVID‐19 syndrome (PCS) and health‐related quality of life (HRQoL)—A systematic review and meta‐analysis351
The emergence and epidemic characteristics of the highly mutated SARS‐CoV‐2 Omicron variant336
Vaccine hesitancy: Beliefs and barriers associated with COVID‐19 vaccination among Egyptian medical students296
Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta‐analysis293
The effect of smoking on COVID‐19 severity: A systematic review and meta‐analysis286
Role of Toll‐like receptors in the pathogenesis of COVID‐19260
A systematic review and meta‐analysis of children with coronavirus disease 2019 (COVID‐19)244
Characterization of the novel SARS‐CoV‐2 Omicron (B.1.1.529) variant of concern and its global perspective217
Obesity aggravates COVID‐19: A systematic review and meta‐analysis208
Current evidence on efficacy of COVID‐19 booster dose vaccination against the Omicron variant: A systematic review204
OMICRON (B.1.1.529): A new SARS‐CoV‐2 variant of concern mounting worldwide fear201
Evaluation of sex‐related hormones and semen characteristics in reproductive‐aged male COVID‐19 patients190
Epidemiological trends and clinical features of the ongoing monkeypox epidemic: A preliminary pooled data analysis and literature review180
Sequence analysis of the emerging SARS‐CoV‐2 variant Omicron in South Africa177
Coinfection in SARS‐CoV‐2 infected patients: Where are influenza virus and rhinovirus/enterovirus?173
A brief review of influenza virus infection173
Relative instantaneous reproduction number of Omicron SARS‐CoV‐2 variant with respect to the Delta variant in Denmark163
Chronic COVID syndrome: Need for an appropriate medical terminology for long‐COVID and COVID long‐haulers163
Detection profile of SARS‐CoV‐2 using RT‐PCR in different types of clinical specimens: A systematic review and meta‐analysis162
SARS‐CoV‐2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG‐I/MDA‐5–MAVS, TLR3–TRIF, and cGAS–STING signaling pathways157
Emerging coronaviruses: Genome structure, replication, and pathogenesis156
Omicron variant (B.1.1.529) of SARS‐CoV‐2, a global urgent public health alert!153
Omicron variant genome evolution and phylogenetics147
A large‐scale meta‐analytic atlas of mental health problems prevalence during the COVID‐19 early pandemic147
Encephalopathy in patients with COVID‐19: A review146
Should RT‐PCR be considered a gold standard in the diagnosis of COVID‐19?141
The epidemiology and clinical characteristics of co‐infection of SARS‐CoV‐2 and influenza viruses in patients during COVID‐19 outbreak132
Vitamin D insufficiency as a potential culprit in critical COVID‐19 patients128
Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Spike mutation T478K126
Long COVID syndrome‐associated brain fog123
Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID‐19121
Extrapulmonary complications of COVID‐19: A multisystem disease?121
Omicron (BA.1) and sub‐variants (BA.1.1, BA.2, and BA.3) of SARS‐CoV‐2 spike infectivity and pathogenicity: A comparative sequence and structural‐based computational assessment121
Emergence of Omicron third lineage BA.3 and its importance120
Analysis of 92 deceased patients with COVID‐19119
Droplet digital PCR of viral ‎DNA/RNA, current progress, challenges, and future perspectives117
Anxiety and depression symptoms after virological clearance of COVID‐19: A cross‐sectional study in Milan, Italy112
Multisystem inflammatory syndrome in children related to COVID‐19: A New York City experience110
Long COVID and chronic COVID syndromes108
Safety of COVID‐19 vaccines107
Obesity aggravates COVID‐19: An updated systematic review and meta‐analysis105
Autoimmune complications of COVID‐19105
Expression of the COVID‐19 receptor ACE2 in the human conjunctiva101
Where have all the viruses gone? Disappearance of seasonal respiratory viruses during the COVID‐19 pandemic100
The “post‐COVID” syndrome: How deep is the damage?99
Non‐life‐threatening adverse effects with COVID‐19 mRNA‐1273 vaccine: A randomized, cross‐sectional study on healthcare workers with detailed self‐reported symptoms98
Risk factors prediction, clinical outcomes, and mortality in COVID‐19 patients97
Evolutionary dynamics of SARS‐CoV‐2 nucleocapsid protein and its consequences96
Anemia is associated with severe illness in COVID‐19: A retrospective cohort study94
Bacterial infections and patterns of antibiotic use in patients with COVID‐1994
Increasing host cellular receptor—angiotensin‐converting enzyme 2 expression by coronavirus may facilitate 2019‐nCoV (or SARS‐CoV‐2) infection94
Targeting human TLRs to combat COVID‐19: A solution?92
Role of toll‐like receptors in modulation of cytokine storm signaling in SARS‐CoV‐2‐induced COVID‐1991
Characterization of the significant decline in humoral immune response six months post‐SARS‐CoV‐2 mRNA vaccination: A systematic review90
Genomic annotation and molecular evolution of monkeypox virus outbreak in 202289
Correlation between a quantitative anti‐SARS‐CoV‐2 IgG ELISA and neutralization activity88
Association between tuberculosis and COVID‐19 severity and mortality: A rapid systematic review and meta‐analysis88
SARS‐CoV‐2 variants and vulnerability at the global level87
The inflammatory markers of multisystem inflammatory syndrome in children (MIS‐C) and adolescents associated with COVID‐19: A meta‐analysis87
Re‐emerging human monkeypox: A major public‐health debacle86
COVID‐19 vaccinations: The unknowns, challenges, and hopes85
Evaluation of seven commercial RT‐PCR kits for COVID‐19 testing in pooled clinical specimens85
Comparative analysis of antiviral efficacy of FDA‐approved drugs against SARS‐CoV‐2 in human lung cells84
Post‐COVID syndrome: A single‐center questionnaire study on 1007 participants recovered from COVID‐1984
High prevalence of SARS‐CoV‐2 and influenza A virus (H1N1) coinfection in dead patients in Northeastern Iran84
Human herpesvirus‐6, ‐7, and Epstein‐Barr virus reactivation in pityriasis rosea during COVID‐1983
The outcome of COVID‐19 in patients with hematological malignancy83
Effects of SARS‐CoV‐2 mutations on protein structures and intraviral protein–protein interactions82
Predictive values of blood urea nitrogen/creatinine ratio and other routine blood parameters on disease severity and survival of COVID‐19 patients82
Alert for non‐respiratory symptoms of coronavirus disease 2019 patients in epidemic period: A case report of familial cluster with three asymptomatic COVID‐19 patients81
Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID‐19 patients80
The global epidemic of SARS‐CoV‐2 variants and their mutational immune escape80
Efficacy of tocilizumab in COVID‐19: A systematic review and meta‐analysis79
The outbreak of SARS‐CoV‐2 Omicron lineages, immune escape, and vaccine effectivity79
0.037320852279663